T1	Participants 255 305	Nineteen patients using a MAS for symptomatic OSAS
T2	Participants 947 1047	successful in four (21%) patients, partially successful in ten (52.6%) and a failure in five (26.3%)
T3	Participants 1154 1176	Fifteen patients (79%)
